Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.
S. Abdul-Rahman, Abdulkareem Shareef, S. Jyothi et al.· Cell Biology International· 0 citations
A comprehensive assessment of advancements and challenges in PSCs, MSCs, RPCs, and RPE, a methodical examination of the disparity between structural engraftment and genuine functional integration, and a cohesive discourse on innovative strategies such as optogenetics, 3D bioprinting, and extracellular vesicle-based the...
B. Jaber, M. Abd, S. Younis et al.· International Immunopharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.